Skip to main content

Gastric Outlet Obstruction

0
Pipeline Programs
5
Companies
6
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Boston Scientific
Boston ScientificCA - Valencia
3 programs
AXIOSN/A1 trial
Hot AXIOS system used for EPASSN/A1 trial
Lumen-apposing metal stentN/A1 trial
Active Trials
NCT06174805Suspended67Est. Apr 2027
NCT05644951Completed51Est. Aug 2025
NCT03259763Completed112Est. Jan 2026
Verona Pharma
Verona PharmaUK - London
1 program
EUS-guided gastroenterostomyN/A1 trial
Active Trials
NCT05605327Unknown120Est. Oct 2024
Eppendorf
EppendorfGermany - Hamburg
1 program
EUS-guided gastrojejunostomyN/A1 trial
Active Trials
NCT05548114Active Not Recruiting74Est. Dec 2025
GT Metabolic Solutions
GT Metabolic SolutionsMN - St. Michael
1 program
Magnet SystemN/A1 trial
Active Trials
NCT07317076Recruiting35Est. Nov 2026
GT Biopharma
GT BiopharmaSAN FRANCISCO, CA
1 program
Magnet SystemN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
GT Metabolic SolutionsMagnet System
Boston ScientificAXIOS
Boston ScientificHot AXIOS system used for EPASS
Verona PharmaEUS-guided gastroenterostomy
EppendorfEUS-guided gastrojejunostomy
Boston ScientificLumen-apposing metal stent

Clinical Trials (6)

Total enrollment: 459 patients across 6 trials

NCT07317076GT Metabolic SolutionsMagnet System

GT Metabolic Magnet System in Adults With Gastrointestinal Disorders

Start: Dec 2025Est. completion: Nov 202635 patients
N/ARecruiting
NCT06174805Boston ScientificAXIOS

AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE

Start: Feb 2025Est. completion: Apr 202767 patients
N/ASuspended
NCT05644951Boston ScientificHot AXIOS system used for EPASS

Clinical Trial of EPASS With Hot AXIOS System

Start: Dec 2022Est. completion: Aug 202551 patients
N/ACompleted
NCT05605327Verona PharmaEUS-guided gastroenterostomy

EUS-guided Versus Laparoscopic Gastrojejunostomy for Malignant Gastric Outlet Obstruction

Start: Nov 2022Est. completion: Oct 2024120 patients
N/AUnknown
NCT05548114EppendorfEUS-guided gastrojejunostomy

Randomized Trial of EUS-guided Gastrojejunostomy and Surgical Gastrojejunostomy in Gastric Outlet Obstruction

Start: Sep 2022Est. completion: Dec 202574 patients
N/AActive Not Recruiting
NCT03259763Boston ScientificLumen-apposing metal stent

EUS-GE vs ES for Palliation of Gastric Outlet Obstruction

Start: Oct 2020Est. completion: Jan 2026112 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 459 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.